ebomi
Colour theme
Sign in
Insider · CIK 0001609492

MPM BioVentures 2014, L.P.

CIK 0001609492 Name as filed on the most recent filing

Filed as MPM BioVentures 2014, L.P. (45)

148 transaction lines · from 45 filings · filed 2019-02-14 to 2025-12-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-12-01 S, Open-market sale iTeos Therapeutics, Inc.ITOS 31,665, disposed Open Form 4 filing 0001209191-21-067706
2021-11-30 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 1,190,902, disposed Open Form 4 filing 0001209191-21-067706
2021-11-29 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 357,656, disposed Open Form 4 filing 0001209191-21-067148
2021-11-26 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 453,110, disposed Open Form 4 filing 0001209191-21-067148
2021-11-24 S, Open-market sale iTeos Therapeutics, Inc.ITOS 3 lines 1,318,543, disposed Open Form 4 filing 0001209191-21-066852
2021-11-23 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 724,449, disposed Open Form 4 filing 0001209191-21-066852
2021-11-22 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 792,271, disposed Open Form 4 filing 0001209191-21-066852
2021-11-02 P, Open-market purchase Entrada Therapeutics, Inc.TRDA 2,000,000, acquired Open Form 4 filing 0001209191-21-062982
2021-10-18 S, Open-market sale iTeos Therapeutics, Inc.ITOS 167,372, disposed Open Form 4 filing 0001209191-21-060723
2021-10-15 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 301,937, disposed Open Form 4 filing 0001209191-21-060723
2021-10-14 S, Open-market sale iTeos Therapeutics, Inc.ITOS 745,836, disposed Open Form 4 filing 0001209191-21-060490
2021-10-13 S, Open-market sale iTeos Therapeutics, Inc.ITOS 567,804, disposed Open Form 4 filing 0001209191-21-060490
2021-10-12 S, Open-market sale iTeos Therapeutics, Inc.ITOS 230,834, disposed Open Form 4 filing 0001209191-21-060490
2021-10-11 S, Open-market sale iTeos Therapeutics, Inc.ITOS 1,329,639, disposed Open Form 4 filing 0001209191-21-060236
2021-10-08 S, Open-market sale iTeos Therapeutics, Inc.ITOS 54,884, disposed Open Form 4 filing 0001209191-21-060236
2021-10-07 S, Open-market sale iTeos Therapeutics, Inc.ITOS 31,023, disposed Open Form 4 filing 0001209191-21-060236
2021-10-04 S, Open-market sale iTeos Therapeutics, Inc.ITOS 560,440, disposed Open Form 4 filing 0001209191-21-059426
2021-10-01 S, Open-market sale iTeos Therapeutics, Inc.ITOS 185,085, disposed Open Form 4 filing 0001209191-21-059426
2021-09-30 S, Open-market sale iTeos Therapeutics, Inc.ITOS 61,884, disposed Open Form 4 filing 0001209191-21-058209
2021-09-28 S, Open-market sale iTeos Therapeutics, Inc.ITOS 518,778, disposed Open Form 4 filing 0001209191-21-058209
2021-09-27 S, Open-market sale iTeos Therapeutics, Inc.ITOS 314,921, disposed Open Form 4 filing 0001209191-21-057823
2021-09-24 S, Open-market sale iTeos Therapeutics, Inc.ITOS 136,631, disposed Open Form 4 filing 0001209191-21-057823
2021-09-23 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 1,032,864, disposed Open Form 4 filing 0001209191-21-057823
2021-09-22 S, Open-market sale iTeos Therapeutics, Inc.ITOS 393,657, disposed Open Form 4 filing 0001209191-21-057414
2021-09-21 S, Open-market sale iTeos Therapeutics, Inc.ITOS 539,373, disposed Open Form 4 filing 0001209191-21-057414
2021-09-20 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 668,008, disposed Open Form 4 filing 0001209191-21-056950
2021-09-17 S, Open-market sale iTeos Therapeutics, Inc.ITOS 1,317,016, disposed Open Form 4 filing 0001209191-21-056950
2021-09-16 S, Open-market sale iTeos Therapeutics, Inc.ITOS 605,073, disposed Open Form 4 filing 0001209191-21-056950
2021-09-15 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 670,207, disposed Open Form 4 filing 0001209191-21-056415
2021-09-14 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 594,703, disposed Open Form 4 filing 0001209191-21-056415
2021-09-13 S, Open-market sale iTeos Therapeutics, Inc.ITOS 591,054, disposed Open Form 4 filing 0001209191-21-055743
2021-09-10 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 382,864, disposed Open Form 4 filing 0001209191-21-055743
2021-09-09 S, Open-market sale iTeos Therapeutics, Inc.ITOS 658,343, disposed Open Form 4 filing 0001209191-21-055743
2021-09-08 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 346,413, disposed Open Form 4 filing 0001209191-21-055210
2021-09-07 S, Open-market sale iTeos Therapeutics, Inc.ITOS 889,231, disposed Open Form 4 filing 0001209191-21-055210
2021-05-04 P, Open-market purchase Werewolf Therapeutics, Inc.HOWL 2,012,144, acquired Open Form 4 filing 0001209191-21-030626

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. MPM BioVentures 2014, L.P., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001609492

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.